Evidence map›Paper›PMID 28318014›Full record

ArticleJournal of computational chemistry2017

"Solvent hydrogen-bond occlusion": A new model of polar desolvation for biomolecular energetics.

Andrea Bazzoli, John Karanicolas

Abstract read
In one paragraph

Article in Journal of computational chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrea BazzoliCenter for Computational Biology, University of Kansas, 2030 Becker Dr, Lawrence, Kansas, 66045-7534.
John KaranicolasCenter for Computational Biology, University of Kansas, 2030 Becker Dr, Lawrence, Kansas, 66045-7534.ORCID 0000-0003-0300-726X

Funding

Identifying inhibitors of protein interactions using pocket optimizationR01GM099959 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI KARANICOLAS, JOHN · 2012 to 2016
$1.4M
NIGMS NIH HHS R01 GM099959
6 · The paper itself

Abstract

Water engages in two important types of interactions near biomolecules: it forms ordered "cages" around exposed hydrophobic regions, and it participates in hydrogen bonds with surface polar groups. Both types of interaction are critical to biomolecular structure and function, but explicitly including an appropriate number of solvent molecules makes many applications computationally intractable. A number of implicit solvent models have been developed to address this problem, many of which treat these two solvation effects separately. Here, we describe a new model to capture polar solvation effects, called SHO ("solvent hydrogen-bond occlusion"); our model aims to directly evaluate the energetic penalty associated with displacing discrete first-shell water molecules near each solute polar group. We have incorporated SHO into the Rosetta energy function, and find that scoring protein structures with SHO provides superior performance in loop modeling, virtual screening, and protein structure prediction benchmarks. These improvements stem from the fact that SHO accurately identifies and penalizes polar groups that do not participate in hydrogen bonds, either with solvent or with other solute atoms ("unsatisfied" polar groups). We expect that in future, SHO will enable higher-resolution predictions for a variety of molecular modeling applications. © 2017 Wiley Periodicals, Inc.

Indexed as

Models, MolecularHydrogenHydrogen BondingHydrophobic and Hydrophilic InteractionsProtein ConformationProteinsSolutionsSolventsStructure-Activity RelationshipThermodynamicsWaterHydrogenProteinsSolutionsSolventsWaterhydration thermodynamicsimplicit solvationRosetta energy function

Identifiers

PMID28318014
PMCPMC5407913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.